Sefia™ Platform Spotlight: Increased Productivity At Commercial Scale

Discover how the Sefia™ platform can transform the commercial-scale manufacturing of CAR T therapies through its advanced automation and intelligent design. By significantly reducing the manual labor and operational resources typically required in cell therapy production, Sefia™ helps streamline workflows and minimize variability, ultimately lowering costs and improving consistency. Its high level of automation not only enhances efficiency but also supports scalability, which makes it easier to transition from clinical to commercial production. Additionally, the platform’s modular architecture offers exceptional flexibility, which allows manufacturers to adapt and expand their processes as needed. This modularity enables increased throughput and productivity to ensure that production can keep pace with growing demand while maintaining high standards of quality and compliance.